Neurology Analysis

Amgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors

FDA · neurology · 8 min

Alzheimer's Clinical Trial Failures: Insights from Semaglutide & Posdinemab FDA Trials

FDA · Alzheimer's disease · 9 min

Alzheimer's Clinical Trial Failures: Novo Nordisk's Semaglutide Phase 3 Outcome & Market Impact

FDA · Alzheimer's disease · 9 min

Alzheimer's Clinical Trial Failures: Impact of Posdinemab Phase 2 Failure on Drug Development

FDA · Alzheimer's disease · 8 min

Alzheimer's Clinical Trial Failures: Impact on US Market & Investment

FDA · Alzheimer's disease · 9 min

FDA Breakthrough Therapy Designations: Impact on Neurological Disorder Investments 2026

FDA · neurological disorders · 11 min

Breakthrough Therapy Designations Drive Neurological Drug Innovation in US

FDA · neurological disorders · 4 min